Veracyte (VCYT) Competitors $40.29 -0.60 (-1.47%) (As of 02:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends VCYT vs. HIMS, GH, OPCH, SHC, BTSG, LFST, SGRY, CON, PRVA, and ARDTShould you be buying Veracyte stock or one of its competitors? The main competitors of Veracyte include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry. Veracyte vs. Hims & Hers Health Guardant Health Option Care Health Sotera Health BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group Ardent Health Partners Veracyte (NASDAQ:VCYT) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, community ranking, media sentiment and profitability. Which has more volatility and risk, VCYT or HIMS? Veracyte has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Does the MarketBeat Community prefer VCYT or HIMS? Veracyte received 402 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 73.01% of users gave Veracyte an outperform vote while only 38.61% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformVeracyteOutperform Votes44173.01% Underperform Votes16326.99% Hims & Hers HealthOutperform Votes3938.61% Underperform Votes6261.39% Does the media prefer VCYT or HIMS? In the previous week, Hims & Hers Health had 24 more articles in the media than Veracyte. MarketBeat recorded 28 mentions for Hims & Hers Health and 4 mentions for Veracyte. Veracyte's average media sentiment score of 1.22 beat Hims & Hers Health's score of 0.52 indicating that Veracyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts rate VCYT or HIMS? Veracyte currently has a consensus target price of $41.13, indicating a potential upside of 0.57%. Hims & Hers Health has a consensus target price of $22.80, indicating a potential downside of 12.98%. Given Veracyte's stronger consensus rating and higher possible upside, research analysts plainly believe Veracyte is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.41 Do insiders & institutionals have more ownership in VCYT or HIMS? 63.5% of Hims & Hers Health shares are owned by institutional investors. 1.3% of Veracyte shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is VCYT or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Veracyte's net margin of -2.18%. Hims & Hers Health's return on equity of 10.97% beat Veracyte's return on equity.Company Net Margins Return on Equity Return on Assets Veracyte-2.18% 3.02% 2.80% Hims & Hers Health 8.19%10.97%8.29% Which has preferable earnings and valuation, VCYT or HIMS? Hims & Hers Health has higher revenue and earnings than Veracyte. Veracyte is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$425.33M7.45-$74.40M-$0.15-272.60Hims & Hers Health$1.24B4.61-$23.55M$0.4459.55 SummaryHims & Hers Health beats Veracyte on 11 of the 18 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCYT vs. The Competition Export to ExcelMetricVeracyteMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.17B$2.85B$5.15B$9.08BDividend YieldN/A15.63%5.12%4.25%P/E Ratio-272.6016.0286.7717.18Price / Sales7.45274.981,119.55117.12Price / Cash465.67472.1143.2337.85Price / Book2.865.194.784.78Net Income-$74.40M-$32.86M$120.55M$225.60M7 Day Performance-5.63%-3.78%-1.48%-1.36%1 Month Performance3.28%0.93%13.95%0.20%1 Year Performance44.64%12.22%28.80%15.30% Veracyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCYTVeracyte4.0703 of 5 stars$40.29-1.5%$41.13+2.1%+44.6%$3.12B$425.33M-268.60790Positive NewsHIMSHims & Hers Health3.3971 of 5 stars$30.93+3.0%$21.43-30.7%+204.8%$6.76B$872M70.251,046Gap UpGHGuardant Health4.2145 of 5 stars$35.13+1.1%$40.60+15.6%+10.2%$4.34B$692.26M-8.201,779OPCHOption Care Health4.8642 of 5 stars$23.40-0.4%$30.14+28.8%-32.1%$3.98B$4.78B19.747,802Positive NewsSHCSotera Health3.5986 of 5 stars$13.01-1.1%$16.08+23.6%-20.4%$3.68B$1.05B52.603,000Positive NewsBTSGBrightSpring Health Services2.2076 of 5 stars$18.95+2.1%$18.50-2.4%N/A$3.30B$10.59B-71.3835,000Positive NewsLFSTLifeStance Health Group1.6971 of 5 stars$7.79+8.6%$8.70+11.7%-5.0%$2.98B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2589 of 5 stars$22.22+9.1%$36.56+64.5%-34.2%$2.82B$2.74B-42.4213,500Positive NewsCONConcentra Group Holdings ParentN/A$21.44+4.6%$28.50+32.9%N/A$2.73B$1.88B0.0011,000Gap UpPRVAPrivia Health Group2.9025 of 5 stars$21.55+2.8%$24.80+15.1%-15.4%$2.59B$1.66B209.621,102ARDTArdent Health PartnersN/A$16.88+1.1%$21.82+29.3%N/A$2.41B$5.71B0.0024,200Positive News Related Companies and Tools Related Companies Hims & Hers Health Competitors Guardant Health Competitors Option Care Health Competitors Sotera Health Competitors BrightSpring Health Services Competitors LifeStance Health Group Competitors Surgery Partners Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors Ardent Health Partners Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VCYT) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
